You are here: Industry Insights > BioNTech

News List

Positive results for Pfizer/BioNTech’s COVID-19 vaccine in 12-15 year olds pharmatimes
April 01, 2021
Pfizer and BioNTech have revealed positive top-line data for their COVID-19 vaccine – BNT162b2 – in adolescents aged 12 to 15 years old.
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna worldpharmanews
March 31, 2021
EMA's human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU.
WHO issues alert for falsified COVID-19 vaccine europeanpharmaceuticalreview
March 30, 2021
The World Health Organization (WHO) has warned that a falsified COVID-19 vaccine, identified as Pfizer’s BNT162b2, could still be in circulation in the Americas.
BioNTech Provides Update on Vaccine Production Status at Marburg Manufacturing Site americanpharmaceuticalreview
March 30, 2021
BioNTech announced the European Medicines Agency (EMA) approved the manufacturing of the COVID-19 vaccine drug product at the facility in Marburg. As part of the process, EMA has approved the production of the drug substance, the mRNA, at the Marburg ...
EMA Approves BioNTech's COVID Vax Production at Marburg Site contractpharma
March 29, 2021
Largest mRNA vaccine manufacturing site in Europe has annual production capacity of up to one billion doses of its COVID-19 vaccine.
A single vaccine dose is sufficient for immunity in COVID-19 survivors, finds study europeanpharmaceuticalreview
March 12, 2021
New research shows a second COVID-19 vaccine dose may be unnecessary in individuals previously infected with SARS-CoV-2 and needlessly exposes individuals to higher rates of adverse effects.
New real-world evidence for Pfizer/BioNTech COVID-19 vaccine pharmatimes
March 12, 2021
New real-world evidence gathered by the Israel Ministry of Health (MoH) suggests that Pfizer/BioNTech’s COVID-19 vaccine ‘dramatically’ lowers the incidence rates of COVID-19 in fully vaccinated individuals.
US accuses Russia of Covid-19 vaccine disinformation campaign pharmaceutical-technology
March 10, 2021
The US Government has accused the Russian intelligence services of carrying out a disinformation campaign aimed at undermining confidence in Western-produced Covid-19 vaccines, including Pfizer and BioNTech’s mRNA product.
FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine americanpharmaceuticalreview
March 04, 2021
The U.S. Food and Drug Administration (FDA) announced it is allowing undiluted frozen vials of the Pfizer-BioNTech COVID-19 Vaccine to be transported and stored at conventional temperatures commonly found in pharmaceutical freezers for a period of up ...
AMRI Contributes to Efforts to Increase COVID-19 Vax Supply contractpharma
February 26, 2021
Albany Molecular Research, Inc. (AMRI) announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page